Because states have flexibility in designing their programs, state Medicaid spending and enrollment varies across states. This data note provides an overview of total Medicaid spending per enrollee by eligibility group and state.
Ostro’s health AI literacy course set a Guinness World Record this week, with 698 participants completing the 30-minute online lesson in 24 hours. The course offers practical training on generative AI, compliance and human-in-the-loop processes to improve understanding across the healthcare and life sciences industries. The post Ostro Breaks a World Record in Its Bid…
The federal government has drastically scaled back the number of recommended childhood immunizations, sidelining six routine vaccines that have safeguarded millions from serious diseases, long-term disability, and death. Just three of the six immunizations the Centers for Disease Control and Prevention says it will no longer routinely recommend — against hepatitis A, hepatitis B, and…
Mayo Clinic recently launched a collaboration with Exer AI, a Denver-based startup. The AI company seeks to improve diagnosis and treatment for musculoskeletal and motion disorders wherever the patient is — whether that be in their provider’s office, their home or via telehealth appointment. The post Mayo Clinic Taps AI Startup to Improve MSK Care…
The Trump administration’s broadsides against scientific research have caused unprecedented upheaval at the National Cancer Institute, the storied federal government research hub that has spearheaded advances against the disease for decades. NCI, which has long benefited from enthusiastic bipartisan support, now faces an exodus of clinicians, scientists, and other staffers — some fired, others leaving…
Merck said topline Phase 3 results show an injectable version of Keytruda met the main goal of non-inferiority compared to the intravenously infused formulation that is the pharma giant’s top-selling product. Injectable Keytruda could help Merck compete against coming competition from biosimilars. The post Merck Gets a Shot of Confidence From Pivotal Test of SubQ…
Colby Takeda is CEO of Pear Suite which has developed a system that helps organizations employing community health workers to track and pay for their work. These community health workers are in multiple social and health organizations. Increasingly states Medicaid and health plans are paying directly to community organizations and Pear Suite is building the…
This summer, at dinner with her best friend, Jacki Barden raised an uncomfortable topic: the possibility that she might die alone. “I have no children, no husband, no siblings,” Barden remembered saying. “Who’s going to hold my hand while I die?” Barden, 75, never had children. She’s lived on her own in western Massachusetts since…
Today, people living with diabetes have several ways of monitoring glucose levels, whether through finger pricks or CGMs. Both ways of measuring glucose levels have benefits and limitations. The post The Future of Glucose Monitoring: Why Blood-Based Measurements Matter appeared first on MedCity News.
This chart collection draws on recent KFF poll findings to provide an in-depth look at the public’s attitudes toward prescription drugs and their prices. Results include Americans’ opinions on drug affordability, pharmaceutical companies, and various potential measures that could lower prices, including the Inflation Reduction Act.